You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RCC

Showing 1 - 25 of 823
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

Not yet recruiting
  • Renal Cell Carcinoma
  • Pembrolizumab injection
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 20, 2023

Advanced Renal Cell Carcinoma Trial in Heilbronn (IVAC)

Recruiting
  • Advanced Renal Cell Carcinoma
  • IVAC
  • Heilbronn, Germany
    SLK Kliniken Heilbronn, Klinik für Innere Medizin III: Hämatolog
Nov 30, 2022

Oligometastatic Disease Trial (IMSA101, Immune checkpoint inhibitor, PULSAR)

Not yet recruiting
  • Oligometastatic Disease
  • (no location specified)
May 5, 2023

Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

Recruiting
  • Renal Cancer
  • +2 more
    • Amsterdam, Noord Holland, Netherlands
      Amsterdam UMC locatie VUMC
    Jan 20, 2023

    RCC, Renal Cell Carcinoma Trial in Dallas (Cabozantinib 80 MG, Cabozantinib 40Mg Tab, Nivolumab)

    Not yet recruiting
    • RCC
    • Renal Cell Carcinoma
    • Cabozantinib 80 MG
    • +2 more
    • Dallas, Texas
      UT Southwestern Medical Center
    Jul 3, 2023

    Implementation of Shared Decision Making Strategy for Renal Cell

    Recruiting
    • Renal Cell Carcinoma
    • Renal Cell Carcinoma Metastatic
    • Decision aid
    • Nieuwegein, Utrecht, Netherlands
      St. Antonius Ziekenhuis
    Nov 28, 2022

    Systemic Treatments in FH-deficient RCC

    Recruiting
    • Metabolomics
    • +3 more
    • Sequencing
    • Shanghai, China
      Yunze Xu
    Aug 15, 2022

    Treatment in FH-deficient RCC Patients

    Recruiting
    • FH-Deficient RCC
    • +2 more
    • Laboratory analysis of samples
    • Shanghai, Shanghai, China
      Ethics Committee of Shanghai Renji Hospital
    Sep 6, 2022

    Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

    Recruiting
    • Advanced Renal Cell Carcinoma
    • ST-1898 tablets
    • Beijing, Beijing, China
      Peking University Cancer Hospital & Institute
    Nov 6, 2023

    Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

    Active, not recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
    • +1 more
    Oct 11, 2022

    Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

    Not yet recruiting
    • Advanced Cancer
    • Clear Cell Renal Cell Carcinoma
    • 177Lu girentuximab
    • +3 more
    • Houston, Texas
      MD Anderson Cancer Center
    Dec 15, 2022

    Kidney Cancer Trial in Birmingham (Acarbose Tablets)

    Not yet recruiting
    • Kidney Cancer
    • Acarbose Tablets
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Aug 2, 2022

    Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)

    Recruiting
    • Recurrent Renal Cell Carcinoma
    • Renal Cell Carcinoma
    • Sulfur Hexafluoride Lipid Microspheres
    • +4 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Nov 29, 2022

    Advanced Renal Cell Carcinoma Trial (QL1706 Plus Lenvatinib)

    Not yet recruiting
    • Advanced Renal Cell Carcinoma
    • QL1706 Plus Lenvatinib
    • (no location specified)
    Feb 21, 2022

    Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)

    Recruiting
    • Renal Cell Carcinoma
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    May 4, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 2, 2022

    Oligoprogressive Renal Cell Carcinoma Trial in Dallas (Stereotactic ablative body radiation (SABR))

    Active, not recruiting
    • Oligoprogressive Renal Cell Carcinoma
    • Stereotactic ablative body radiation (SABR)
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Nov 28, 2022

    Advanced Kidney Cancer Trial in Tianjin (Tislelizumab Lenvatinib)

    Recruiting
    • Advanced Kidney Cancer
    • Tislelizumab Lenvatinib
    • Tianjin, Tianjin, China
      Changyi Quan
    Aug 4, 2022

    Advanced Kidney Cancer Trial in Tianjin (Pembrolizumab plus Lenvatinib)

    Recruiting
    • Advanced Kidney Cancer
    • Pembrolizumab plus Lenvatinib
    • Tianjin, Tianjin, China
      Changyi Quan
    Aug 4, 2022

    Preferences of Participants and Oncologists for Characteristics

    Completed
    • Renal Cell Carcinoma
      • Castellon de La Plana, Spain
        Local Institution
      Dec 8, 2021

      Japanese RCC Patients Treated With Avelumab Plus Axitinib as

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Jan 18, 2023

      Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

      Recruiting
      • Carcinoma
      • +4 more
        • Nanjing, Jiangsu, China
          Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
        Jun 30, 2023

        Advanced Solid Tumors, Solid Tumor, Solid Carcinoma Trial (Belzutifan)

        Active, not recruiting
        • Advanced Solid Tumors
        • +15 more
        • (no location specified)
        Sep 16, 2022

        Renal Cell Carcinoma (RCC) Trial in Birmingham (Trans-arterial embolization (TAE))

        Not yet recruiting
        • Renal Cell Carcinoma (RCC)
        • Trans-arterial embolization (TAE)
        • Birmingham, Alabama
          University of Alabama at Birmingham
        Dec 5, 2022

        Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

        Not yet recruiting
        • Melanoma
        • +5 more
        • INCB 99280 with Ipilimumab
        • (no location specified)
        Jun 9, 2023